Skip to main content
Clinical Trials/NCT02853955
NCT02853955
Unknown
Not Applicable

MitraClip® for the Treatment of Recurrent Severe Mitral Regurgitation After Surgical Mitral Valve Repair

LMU Klinikum1 site in 1 country30 target enrollmentMay 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Mitral Regurgitation
Sponsor
LMU Klinikum
Enrollment
30
Locations
1
Primary Endpoint
Survival
Last Updated
9 years ago

Overview

Brief Summary

Percutaneous edge-to-edge repair of the mitral valve has been shown to be a safe and effective alternative treatment option for selected patients at high risk for cardiac surgery. Patients with recurrent mitral regurgitation after surgical mitral valve repair (sMVR) are per se at increased risk for another cardiac surgery. The purpose of this multicenter retrospective analysis of patients treated with a MitraClip® after sMVR, is to evaluate the effectiveness and durability of this minimally invasive treatment option in this subset of patients.

Detailed Description

In this multicenter retrospective analysis of MitraClip® cases after MVR the effectiveness and durability of this minimally invasive treatment option in this subset of patients will be evaluated.

Registry
clinicaltrials.gov
Start Date
May 2016
End Date
November 2016
Last Updated
9 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
LMU Klinikum
Responsible Party
Principal Investigator
Principal Investigator

Daniel Braun, MD

MD

LMU Klinikum

Eligibility Criteria

Inclusion Criteria

  • All patients with recurrent mitral regurgitation treated with a MitraClip®.

Exclusion Criteria

  • Patient with endocarditis,
  • Patients with torn mitral valve ring.

Outcomes

Primary Outcomes

Survival

Time Frame: 1 year

MR (mitral regurgitation) grade after clip treatment

Time Frame: 1 year

Scale 0-4

Secondary Outcomes

  • NYHA status at latest follow up(1 year)
  • Distance in 6 minute walk test at latest follow up(1 year)
  • MR (mitral regurgitation) grade at latest follow up(1 year)
  • LVEF (left ventricular ejection fraction) at latest follow up(1 year)
  • LVEDV (left ventricular enddiastolic volume) at latest follow up(1 year)
  • LVEDD (lef ventricular enddiastolic diameter) at latest follow up(1 year)
  • Mean mitral valve gradient(1 year)
  • Death, recurrent mitral regurgitation grade > 2, repeat intervention/operation of mitral valve(1 year)
  • Procedural complications(index procedure)
  • Clip success based on type of sMVR(index procedure)

Study Sites (1)

Loading locations...

Similar Trials